Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP.
Velasco Rodríguez-Belvís M, Palomino L, Pujol-Muncunill G, Martin-Masot R, Medina Benítez E, Fernández-Lorenzo AE, Moreno-Álvarez A, Molina Arias M, Hidalgo Montes I, Barrio Torres J, Navas-López VM, Martín de Carpi J, Lozano Ruf A, Blasco-Alonso J, Barrio Torres J, Montraveta M, Peña-Quintana L, Ramos Rueda N, Rodríguez Martínez A, Botija Arcos G, Alonso Vicente C, Castro Millán AM, Donat E, Fernández Cebrián S, Sánchez Sánchez C, Loverdos I, Segarra Cantón O, Ruiz Castellano N, Torres-Peral R, Crehuá-Gaudiza E, Millán Jiménez A, Jovani Casano C, Vicente Santamaría S, Tabares González A, Garcia-Romero R, Ros Arnal I, Balboa Vega MJ, Escartín Madurga L, Martinón Torres N, Crujeiras Martínez V, González-Vives L, Pérez-Moneo B, Masiques Mas ML, Vegas Álvarez AM, Grande Herrero L, La Orden Izquierdo E, Chicano Marín FJ, de Las Mercedes Busto Cuiñas M, Martínez de Zabarte Fernández JM, Alberto Alonso JR, Andrés Esteban EM. Velasco Rodríguez-Belvís M, et al. Among authors: montraveta m. Eur J Pediatr. 2024 May 21. doi: 10.1007/s00431-024-05575-7. Online ahead of print. Eur J Pediatr. 2024. PMID: 38771373
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
Salvador-Martín S, Rubbini G, Vellosillo P, Zapata-Cobo P, Velasco M, Palomino LM, Clemente S, Segarra O, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Montraveta M, Sánchez C, Tolín M, Loverdos I, Fobelo MJ, Navas-López VM, Magallares L, García-Romero R, Torres-Peral R, Rodríguez A, Bossacoma F, Merino-Bohórquez V, Salcedo E, Álvarez R, Dopazo A, Sanjurjo-Sáez M, López-Fernández LA. Salvador-Martín S, et al. Among authors: montraveta m. Biomed Pharmacother. 2024 Apr;173:116299. doi: 10.1016/j.biopha.2024.116299. Epub 2024 Feb 23. Biomed Pharmacother. 2024. PMID: 38401525 Free article.
Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The LiverKids: Study protocol.
Chacón C, Arteaga I, Martínez-Escudé A, Ruiz Rojano I, Lamonja-Vicente N, Caballeria L, Ribatallada Diez AM, Schröder H, Montraveta M, Bovo MV, Ginés P, Pera G, Diez-Fadrique G, Pachón-Camacho A, Alonso N, Graupera I, Torán-Monserrat P, Expósito C. Chacón C, et al. Among authors: montraveta m. PLoS One. 2023 Oct 13;18(10):e0286586. doi: 10.1371/journal.pone.0286586. eCollection 2023. PLoS One. 2023. PMID: 37831682 Free PMC article.
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Zapata-Cobo P, Salvador-Matín S, Velasco M, Palomino LM, Clemente S, Segarra O, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Montraveta M, Sánchez C, Tolín M, Loverdos I, Fobelo MJ, Navas-López VM, Magallares L, García-Romero R, Sánchez-Hernández JG, Rodríguez A, Bossacoma F, Balboa MJ, Salcedo E, Sanjurjo-Sáez M, López-Fernández LA. Zapata-Cobo P, et al. Among authors: montraveta m. Pharmacol Res. 2023 Oct;196:106938. doi: 10.1016/j.phrs.2023.106938. Epub 2023 Sep 23. Pharmacol Res. 2023. PMID: 37748560 Free article. No abstract available.
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Zapata-Cobo P, Salvador-Martín S, Velasco M, Palomino LM, Clemente S, Segarra O, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Montraveta M, Sánchez C, Tolín M, Loverdos I, Fobelo MJ, Navas-López VM, Magallares L, García-Romero R, Sánchez-Hernández JG, Rodríguez A, Bossacoma F, Balboa MJ, Salcedo E, Sanjurjo-Sáez M, López-Fernández LA. Zapata-Cobo P, et al. Among authors: montraveta m. Pharmacol Res. 2023 Aug;194:106859. doi: 10.1016/j.phrs.2023.106859. Epub 2023 Jul 19. Pharmacol Res. 2023. PMID: 37473877 Free article.
Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study.
Garcia-Romero R, de Zabarte Fernandez JMM, Pujol-Muncunill G, Donat-Aliaga E, Segarra-Cantón O, Irastorza-Terradillos I, Medina-Benitez E, Ruiz-Hernández CJ, Carrillo-Palau M, Ros-Arnal I, Rodriguez-Martínez A, Escartin-Madurga L, Gutiérrez-Junquera C, Vicente-Santamaría S, Rodriguez-Belvis MV, Fernández-Fernández S, Alberto-Alonso JR, Montraveta M, Torres-Peral R, Navalon-Rubio M, Navas-López VM, de Carpi JM. Garcia-Romero R, et al. Among authors: montraveta m. Eur J Pediatr. 2021 Sep;180(9):3039-3040. doi: 10.1007/s00431-021-04117-9. Eur J Pediatr. 2021. PMID: 34027626 Free article. No abstract available.
Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.
Garcia-Romero R, Martinez de Zabarte Fernandez JM, Pujol-Muncunill G, Donat-Aliaga E, Segarra-Cantón O, Irastorza-Terradillos I, Medina-Benitez E, Ruiz-Hernández CJ, Carrillo-Palau M, Ros-Arnal I, Rodriguez-Martínez A, Escartin-Madurga L, Gutiérrez-Junquera C, Vicente-Santamaría S, Velasco Rodriguez-Belvis M, Fernández-Fernández S, Alberto-Alonso JR, Montraveta M, Torres-Peral R, Navalon-Rubio M, Navas-López VM, Martin de Carpi J. Garcia-Romero R, et al. Among authors: montraveta m. Eur J Pediatr. 2021 Sep;180(9):3029-3038. doi: 10.1007/s00431-021-04063-6. Epub 2021 Apr 20. Eur J Pediatr. 2021. PMID: 33880650
The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry.
Martín-de-Carpi J, Rodríguez A, Ramos E, Jiménez S, Martínez-Gómez MJ, Medina E, Navas-López VM; SPIRIT-IBD Working Group of SEGHNP (Sociedad Española de Gastroenterología Hepatología Nutrición Pediátrica). Martín-de-Carpi J, et al. J Crohns Colitis. 2014 Aug;8(8):763-9. doi: 10.1016/j.crohns.2014.01.005. Epub 2014 Jan 24. J Crohns Colitis. 2014. PMID: 24462789
14 results